Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Doru T. Alexandrescu, Alexandria Garino, Kelly A. Brown-Balem & Peter H. Wiernik. (2006) Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree. Leukemia & Lymphoma 47:10, pages 2115-2127.
Read now
Read now
Janet Cuttner, J. Lawrence Werther, Pat McGlynn, Anli Chen, Carol Bodian, Shunichiro Ogata, James Strauchen, Kevin Troy & Steven Itzkowitz. (2001) Seroprevalence of Helicobacter Pylori Infection in Patients with Lymphoma. Leukemia & Lymphoma 40:5-6, pages 591-597.
Read now
Read now
Reiner Siebert, Alexander Fosså, Wolfgang Kaiser, Anja Welt, Stanislav Ferencik, Siegfried Seeber & Mohammad R. Nowrousian. (1997) Recurrence of hodgkin's disease after 10 or more years: Late relapse or de-Novo malignancy due to HLA-DPB1* 0301-linked susceptibility?. Leukemia & Lymphoma 26:1-2, pages 121-125.
Read now
Read now
Reiner Siebert, Diane Louie, Mortimer Lacher, Alice Schluger & Kenneth Offit. (1997) Familial Hodgkin's and Non-Hodgkin's Lymphoma: Different Patterns in First-Degree Relatives. Leukemia & Lymphoma 27:5-6, pages 503-507.
Read now
Read now
A. Stuart Douglas, Tom Brown & Daniel Reid. (1996) Infectious Mononucleosis and Hodgkin's Disease—a Similar Seasonality. Leukemia & Lymphoma 23:3-4, pages 323-331.
Read now
Read now
E. Teske. (1994) Canine malignant lymphoma: A review and comparison with human non‐hodgkin's lymphoma. Veterinary Quarterly 16:4, pages 209-219.
Read now
Read now
Articles from other publishers (25)
Stephen M. Ansell. (2022) Hodgkin lymphoma: 2023 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 97:11, pages 1478-1488.
Crossref
Crossref
Stephen M. Ansell. (2020) Hodgkin lymphoma: A 2020 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 95:8, pages 978-989.
Crossref
Crossref
K.D. Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova & E.G. Gemdzhian. (2019) Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry. Clinical oncohematology 12:4, pages 3-16.
Crossref
Crossref
Stephen M. Ansell. (2018) Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management. American Journal of Hematology 93:5, pages 704-715.
Crossref
Crossref
Stephen M. Ansell. (2016) Hodgkin lymphoma: 2016 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 91:4, pages 434-442.
Crossref
Crossref
Stephen M. Ansell. (2015) Hodgkin Lymphoma: Diagnosis and Treatment. Mayo Clinic Proceedings 90:11, pages 1574-1583.
Crossref
Crossref
Sally L. Glaser, Ellen T. Chang, Christina A. Clarke & Theresa H. Keegan. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma
3
26
.
Stephen M. Ansell. (2014) Hodgkin lymphoma: 2014 update on diagnosis, risk-stratification, and management. American Journal of Hematology 89:7, pages 771-779.
Crossref
Crossref
Preethi R. Marri & Stephen M. Ansell. (2013) Progress in the initial management of Hodgkin?s Lymphoma. Transfusion and Apheresis Science 49:1, pages 12-18.
Crossref
Crossref
Stephen M. Ansell. (2012) Hodgkin lymphoma: 2012 update on diagnosis, risk-stratification, and management. American Journal of Hematology 87:12, pages 1096-1103.
Crossref
Crossref
Stephen M. Ansell. (2011) Hodgkin lymphoma: 2011 update on diagnosis, risk‐stratification, and management. American Journal of Hematology 86:10, pages 851-858.
Crossref
Crossref
Sally L. Glaser, Ellen T. Chang, Christina A. Clarke & Theresa H. Keegan. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma
3
20
.
Samer A. Srour & Luis E. Fayad. 2010. Neoplastic Hematopathology. Neoplastic Hematopathology
367
389
.
Doru T. Alexandrescu & Peter H. Wiernik. (2007) The influence of parental age and gender on anticipation in familial B-Cell malignancies. Medical Oncology 24:1, pages 55-62.
Crossref
Crossref
Stephen M. Ansell & James O. Armitage. (2006) Management of Hodgkin Lymphoma. Mayo Clinic Proceedings 81:3, pages 419-426.
Crossref
Crossref
Andrea AltieriJusto Lorenzo BermejoKari Hemminki. (2005) Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood 106:2, pages 668-672.
Crossref
Crossref
Daniel GreenManuel Diezi & David Malkin. 2003. Late Effects of Childhood Cancer. Late Effects of Childhood Cancer
70
CP4
.
Caroline Bäumler, Fei Duan, Kenan Onel, Beth Rapaport, Suresh Jhanwar, Kenneth Offit & Keith B. Elkon. (2003) Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients. Leukemia Research 27:9, pages 841-851.
Crossref
Crossref
Reiner Siebert. 2003. Molekularmedizinische Grundlagen von hämatologischen Neoplasien. Molekularmedizinische Grundlagen von hämatologischen Neoplasien
65
86
.
Bradley C. Ekstrand & Sandra J. Horning. (2002) Hodgkin's disease. Blood Reviews 16:2, pages 111-117.
Crossref
Crossref
William B. Goggins, Dianne M. Finkelstein & Hensin Tsao. (2001) Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 91:4, pages 874-880.
Crossref
Crossref
Ora Paltiel, Tal Schmit, Bella Adler, Eliezer A. Rachmilevitz, Aaron Polliack, Amos Cohen, Nissim Haim, Menachem Ben Shachar, Ron Epelbaum, Micha Barchana, Ronit Cohen & Dina Ben Yehuda. (2000) The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma. Cancer 88:10, pages 2357-2366.
Crossref
Crossref
Peter H. Wiernik, Steven Q. Wang, Xiao‐Ping Hu, Patricia Marino & Elisabeth Paietta. (2001) Age of onset evidence for anticipation in familial non‐Hodgkin's lymphoma. British Journal of Haematology 108:1, pages 72-79.
Crossref
Crossref
M. Gerold & R. Adler. (1995) Hodgkin's disease as an indicator of AIDS. Medical Hypotheses 45:1, pages 76-82.
Crossref
Crossref
Volker Diehl & Hans Tesch. (1995) Hodgkin's Disease — Environmental or Genetic?. New England Journal of Medicine 332:7, pages 461-463.
Crossref
Crossref